Holly Vance

Insider Reports History

Entity
Individual
Location
C/O Neoleukin Therapeutics, Inc., 360 1616 Eastlake Avenue E., Seattle, WA
Signature
/s/ Kris McGrew, Attorney-in-Fact for Holly Vance
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Holly Vance:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Neoleukin Therapeutics, Inc. General Counsel Stock Option (Right to Buy) 100K Aug 3, 2021 Direct

Insider Reports Filed by Holly Vance

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NLTX Neoleukin Therapeutics, Inc. Aug 3, 2021 1 $0 4 Aug 5, 2021 General Counsel